CSIFX
Price
$43.98
Change
-$0.19 (-0.43%)
Updated
May 23 closing price
Net Assets
1.33B
RLBBX
Price
$34.53
Change
-$0.05 (-0.14%)
Updated
May 23 closing price
Net Assets
237.45B
Interact to see
Advertisement

CSIFX vs RLBBX

Header iconCSIFX vs RLBBX Comparison
Open Charts CSIFX vs RLBBXBanner chart's image
Calvert Balanced A
Price$43.98
Change-$0.19 (-0.43%)
VolumeN/A
Net Assets1.33B
American Funds American Balanced R2
Price$34.53
Change-$0.05 (-0.14%)
VolumeN/A
Net Assets237.45B
CSIFX vs RLBBX Comparison Chart
Loading...
View a ticker or compare two or three
VS
CSIFX vs. RLBBX commentary
May 25, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CSIFX is a Buy and RLBBX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RLBBX has more cash in the bank: 237B vs. CSIFX (1.33B). CSIFX pays higher dividends than RLBBX: CSIFX (1.40) vs RLBBX (1.27). CSIFX was incepted earlier than RLBBX: CSIFX (43 years) vs RLBBX (23 years). RLBBX (1.32) is less costly to investors than CSIFX (0.90). CSIFX is a more actively managed with annual turnover of: 153.00 vs. RLBBX (44.00). RLBBX has a lower initial minimum investment than CSIFX: RLBBX (250) vs CSIFX (1000). CSIFX annual gain was more profitable for investors over the last year : 5.55 vs. RLBBX (4.44). CSIFX return over 5 years is better than : 40.43 vs. RLBBX (33.58).
CSIFXRLBBXCSIFX / RLBBX
Total Expense Ratio0.901.3268%
Annual Report Gross Expense Ratio0.901.3268%
Fund Existence43 years23 years-
Gain YTD-0.6521.539-42%
Front Load5%N/A-
Min. Initial Investment1000250400%
Min. Initial Investment IRAN/AN/A-
Net Assets1.33B237B1%
Annual Yield % from dividends1.401.27110%
Returns for 1 year5.554.44125%
Returns for 3 years28.4120.04142%
Returns for 5 years40.4333.58120%
Returns for 10 years45.3746.6397%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AEON0.530.05
+9.88%
AEON Biopharma
USAC25.010.35
+1.42%
USA Compression Partners LP
NBIX120.181.06
+0.89%
Neurocrine Biosciences
CSTE1.78-0.01
-0.56%
Caesarstone Ltd
EGBN17.47-0.19
-1.08%
Eagle Bancorp